Skip to main content
. 2021 Jan;10(1):304–313. doi: 10.21037/tlcr-20-380

Figure 3.

Figure 3

PLS-DA blot of NSCLC patients. Red: before treatment start; blue: progressing on treatment and green: responding on treatment. PLS-DA, partial least squares discriminant analysis.